Company
Last deal
$20.97M
Local Amount - GBP 16.5M
Amount
Series A
Stage
20.06.2024
Date
1
all rounds
$20.97M
Total amount
Financing round
General
About Company
Yellowstone seeks to identify a novel class of frequently expressed antigens that can be therapeutically targeted.
Also Known As
Yellowstone Bio
Last funding type
Series A
IPO status
Private
Contacts
Contact Email
Website URL
Financials
Funding Rounds1
1
Number of Funding Rounds
$20.97M
Money Raised
Their latest funding was raised on 20.06.2024. Their latest investor Syncona Partners LLP. Their latest round Series A
Date
Funding Round
Investors
Money Raised
Lead
Syncona Partners LLP
Syncona Partners LLP is a healthcare company that invests in and builds global leaders in life science.
Sector
Health Care Providers
Subsector
Health Care Services
Keywords
Health Care, Financial Services, Venture Capital
Location
London, UK
count Of Investments
41
count Of Exists
4
Co-Investors
Investors1
1
Number of lead investors
1
Number of investors
Investor
Lead
Round
Partners
Syncona Partners LLP
Syncona Partners LLP is a healthcare company that invests in and builds global leaders in life science.
Sector
Health Care Providers
Subsector
Health Care Services
Keywords
Health Care, Financial Services, Venture Capital
Location
London, UK
count Of Investments
41
count Of Exists
4